EBV-related lymphoma after long-term daratumumab treatment: a case report

por Verpoorte-Botden, Ilse P. G., Minnema, Monique C., Raymakers, Reinier A. P.
Publicado 2020

CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

por Leguit, Roos J., Raymakers, Reinier A. P., Hebeda, Konnie M., Goldschmeding, Roel
Publicado 2021

The Tetraspanin Protein CD37 Regulates IgA Responses and Anti-Fungal Immunity

por van Spriel, Annemiek B., Sofi, Mariam, Gartlan, Kate H., van der Schaaf, Alie, Verschueren, Ineke, Torensma, Ruurd, Raymakers, Reinier A. P., Loveland, Bruce E., Netea, Mihai G., Adema, Gosse J., Wright, Mark D., Figdor, Carl G.
Publicado 2009

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chron...

por Kater, Arnon P., van Oers, Marinus H.J., van Norden, Yvette, van der Straten, Lina, Driessen, Julia, Posthuma, Ward F.M., Schipperus, Martin, Chamuleau, Martine E.D., Nijland, Marcel, Doorduijn, Jeanette K., Van Gelder, Michel, Hoogendoorn, Mels, De Croon, Francien, Wittebol, Shulamiet, Kerst, J. Martijn, Marijt, Erik W.A., Raymakers, Reinier A.P., Schaafsma, Martijn R., Dobber, Johan A., Kersting, Sabina, Levin, Mark-David
Publicado 2019